Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
WA

NASDAQ · WALDW

Waldencast plc

Technology · Software - Application

$0.01

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 8:22 AM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
4.52M
P/E ratio
-5.22
Dividend yield
0.00%
52-week range
$0.00 – $0.07
Volume
438.28K
Avg. volume
32.44K

Price performance · WALDW

WALDW price history

1M range · 0 trading sessions · Daily adjusted prices

WALDW does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest WALDW news

The latest Smart Investors Daily articles mentioning WALDW.

Stock researchCompany · Overview

WALDW research

Overview

Company profile and research snapshot.

Company profile

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 28, 2026

Waldencast plc Announces First Half 2026 Financial Results

NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of Milk Studios in downtown New York City, today announced operating results for the six months ended June 30, 2026 (“H1 2026”) and provided a business update. On July 30, 2026, the Company completed the sale of the Obagi Medical business to Bridgepoint. The Company determined that this disp

Yahoo · Sep 14, 2026

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Board to recommend that shareholders approve renaming the Company Milk Makeup plc The Company’s Board of Directors has approved the voluntary delisting of the Company’s Class A Ordinary Shares and Warrants from Nasdaq and the deregistration of those securities under the Exchange Act.Company expects to file a Form 25 with the SEC on or about September 24, 2026; delisting expected to become effective on or about October 4, 2026, with the last day of trading on Nasdaq expected to be October 2, 2026

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By